社论：创新药物倡议——合作是创新研发流程的关键。 - Suppr

Suppr

超能文献

Editorial: The Innovative Medicines Initiative--collaborations are key to innovating R&D processes.

作者信息

Laverty Hugh, Goldman Michel

机构信息

Innovative Medicines Initiative (IMI) - Executive Office.

出版信息

Biotechnol J. 2014 Sep;9(9):1095-6. doi: 10.1002/biot.201400487.

DOI:10.1002/biot.201400487

PMID:25174501

Abstract

摘要

相似文献

Editorial: The Innovative Medicines Initiative--collaborations are key to innovating R&D processes.

Biotechnol J. 2014 Sep;9(9):1095-6. doi: 10.1002/biot.201400487.

Trial watch: personalized medicines in late-stage development.

Nat Rev Drug Discov. 2014 May;13(5):324-5. doi: 10.1038/nrd4325.

The innovative medicines initiative: a case study for new ways of working in drug R&D.

Future Med Chem. 2014 Apr;6(5):489-91. doi: 10.4155/fmc.14.22.

News & Analysis: new initiative aims to improve success of early stage drug discovery.

Future Med Chem. 2014 May;6(7):733. doi: 10.4155/fmc.14.61.

Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?

Expert Rev Clin Pharmacol. 2015 Jan;8(1):77-94. doi: 10.1586/17512433.2015.990380.

The Critical Path Institute's approach to precompetitive sharing and advancing regulatory science.

Clin Pharmacol Ther. 2010 May;87(5):530-3. doi: 10.1038/clpt.2010.27.

Personalized medicine: a paradigm for a sustainable pharmaceutical industry?

Curr Opin Drug Discov Devel. 2009 Jul;12(4):443-5.

Grants4Targets: an open innovation initiative to foster drug discovery collaborations.

Nat Rev Drug Discov. 2015 Jan;14(1):74-6. doi: 10.1038/nrd3078-c2. Epub 2014 Nov 28.

Pharmacotherapy crisis in the spotlight--is open collaboration between academia and industry the answer?

Cardiovasc Drugs Ther. 2011 Apr;25(2):187-8. doi: 10.1007/s10557-011-6297-5.

Organizing for innovation: towards successful translational research.

Trends Biotechnol. 2009 Oct;27(10):558-61. doi: 10.1016/j.tibtech.2009.06.007. Epub 2009 Aug 14.

引用本文的文献

The Innovative Medicines Initiative -10 Years of Public-Private Collaboration.

Front Med (Lausanne). 2019 Dec 3;6:275. doi: 10.3389/fmed.2019.00275. eCollection 2019.

Proficiency Testing of Standardized Samples Shows Very High Interlaboratory Agreement for Clinical Next-Generation Sequencing-Based Oncology Assays.

Arch Pathol Lab Med. 2019 Apr;143(4):463-471. doi: 10.5858/arpa.2018-0336-CP. Epub 2018 Oct 30.

Opportunities and Challenges for Drug Development: Public-Private Partnerships, Adaptive Designs and Big Data.

Front Pharmacol. 2016 Dec 6;7:461. doi: 10.3389/fphar.2016.00461. eCollection 2016.

Preclinical research strategies for newly approved drugs as reflected in early publication patterns.

Naunyn Schmiedebergs Arch Pharmacol. 2016 Feb;389(2):187-99. doi: 10.1007/s00210-015-1187-1. Epub 2015 Nov 26.

Expectations and satisfaction of academic investigators in nonclinical collaboration with the pharmaceutical industry.

Naunyn Schmiedebergs Arch Pharmacol. 2015 Jun;388(6):613-22. doi: 10.1007/s00210-015-1106-5. Epub 2015 Feb 28.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验